Bussiness4 months ago
Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
Century Therapeutics, Inc. – Initiation of Phase 1 CALiPSO-1 Trial of CNTY-101 in Systemic Lupus Erythematosus, marking strategic expansion into autoimmune disease; protocol amended to include...
